Advertisement

Clinical Aspect: Esophageal Cancer

  • Itaru OmotoEmail author
  • Yasuto Uchikado
  • Ken Sasaki
  • Takaaki Arigami
  • Shoji Natsugoe
Chapter

Abstract

Lymph node micrometastasis (LNM), including isolated tumor cells (ITC), has recently been the focus of study for the development of a biological method to detect lymph node metastasis in various malignant neoplasms. The applicability of immunohistochemistry (IHC) and reverse transcription-polymerase chain reactions (RT-PCR) to the detection of LNM in esophageal cancer has already been reported. However, the clinical significance of LNM currently remains unclear in patients with esophageal cancer. The presence of LNM is clinically important in patients without nodal metastasis in a routine histological examination (pN0) because patients with pN0, but also with LNM already exhibit metastatic potential. Accurate evaluations need to be performed using the same antibody or primer as well as the same technique in a large number of patients. A rapid diagnosis of LNM using IHC and RT-PCR during surgery will be clinically useful. Minimally invasive treatments such as endoscopic submucosal dissection and laparoscopic surgery with individualized lymphadenectomy are now being increasingly performed in consideration of postsurgical quality of life (QOL). However, it is important to maintain the balance between QOL and curability when selecting surgical treatments for patients with esophageal cancer. We reviewed the clinical significance of LNM as an important strategic target in patients with esophageal cancer.

Keywords

Lymph node micrometastasis Esophageal cancer Minimally invasive surgery 

References

  1. 1.
    Robey-Cafferty SS, el-Naggar AK, Sahin AA, Bruner JM, Ro JY, Cleary KR. Prognostic factors in esophageal squamous carcinoma. A study of histologic features, blood group expression, and DNA ploidy. Am J Clin Pathol. 1991;95(6):844–9.PubMedGoogle Scholar
  2. 2.
    Roder JD, Busch R, Stein HJ, Fink U, Siewert JR. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg. 1994;81(3):410–3.PubMedGoogle Scholar
  3. 3.
    Dimick JB, Pronovost PJ, Cowan JA Jr, Lipsett PA, Stanley JC, Upchurch GR Jr. Variation in postoperative complication rates after high-risk surgery in the United States. Surgery. 2003;134(4):534–40. discussion 40-1PubMedGoogle Scholar
  4. 4.
    Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346(15):1128–37.PubMedGoogle Scholar
  5. 5.
    Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. JAMA. 1998;280(20):1747–51.PubMedGoogle Scholar
  6. 6.
    Lambert R. Treatment of esophagogastric tumors. Endoscopy. 2003;35(2):118–26.PubMedGoogle Scholar
  7. 7.
    Tilanus HW, Hop WC, Langenhorst BL, van Lanschot JJ. Esophagectomy with or without thoracotomy. Is there any difference? J Thorac Cardiovasc Surg. 1993;105(5):898–903.PubMedGoogle Scholar
  8. 8.
    Uenosono Y, Arigami T, Yanagita S, Kozono T, Arima H, Hirata M, et al. Sentinel node navigation surgery is acceptable for clinical T1 and N0 esophageal cancer. Ann Surg Oncol. 2011;18(7):2003–9.PubMedGoogle Scholar
  9. 9.
    Hagihara T, Uenosono Y, Arigami T, Kozono T, Arima H, Yanagita S, et al. Assessment of sentinel node concept in esophageal cancer based on lymph node micrometastasis. Ann Surg Oncol. 2013;20(9):3031–7.PubMedGoogle Scholar
  10. 10.
    Takeuchi H, Kawakubo H, Takeda F, Omori T, Kitagawa Y. Sentinel node navigation surgery in early-stage esophageal cancer. Ann Thorac Cardiovasc Surg. 2012;18(4):306–13.PubMedGoogle Scholar
  11. 11.
    Natsugoe S, Aikou T, Shimada M, Yoshinaka H, Takao S, Shimazu H, et al. Occult lymph node metastasis in gastric cancer with submucosal invasion. Surg Today. 1994;24(10):870–5.PubMedGoogle Scholar
  12. 12.
    Izbicki JR, Hosch SB, Pichlmeier U, Rehders A, Busch C, Niendorf A, et al. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med. 1997;337(17):1188–94.PubMedGoogle Scholar
  13. 13.
    Natsugoe S, Mueller J, Stein HJ, Feith M, Hofler H, Siewert JR. Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma: frequency, associated tumor characteristics, and impact on prognosis. Cancer. 1998;83(5):858–66.PubMedGoogle Scholar
  14. 14.
    Matsumoto M, Natsugoe S, Nakashima S, Sakamoto F, Okumura H, Sakita H, et al. Clinical significance of lymph node micrometastasis of pN0 esophageal squamous cell carcinoma. Cancer Lett. 2000;153(1–2):189–97.PubMedGoogle Scholar
  15. 15.
    Arigami T, Natsugoe S, Uenosono Y, Mataki Y, Ehi K, Higashi H, et al. Evaluation of sentinel node concept in gastric cancer based on lymph node micrometastasis determined by reverse transcription-polymerase chain reaction. Ann Surg. 2006;243(3):341–7.PubMedPubMedCentralGoogle Scholar
  16. 16.
    Mori M, Mimori K, Inoue H, Barnard GF, Tsuji K, Nanbara S, et al. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res. 1995;55(15):3417–20.PubMedGoogle Scholar
  17. 17.
    Raj GV, Moreno JG, Gomella LG. Utilization of polymerase chain reaction technology in the detection of solid tumors. Cancer. 1998;82(8):1419–42.PubMedGoogle Scholar
  18. 18.
    Sobin L, Wittekind C. TNM classification of malignant tumours. 6th ed. New York: Wiley; 2002. (International Union Against Cancer)Google Scholar
  19. 19.
    Sobin L, Wittenkind C. TNM classification of malignant tumors. 6th ed. New York: John Wiley-Liss; 2002.Google Scholar
  20. 20.
    Kinjo T, Shimoji H, Nagahama M, Karimata H, Yoshimi N, Nishimaki T. Prognostic significance of simultaneous presence of histological and immunohistochemical metastasis to lymph nodes in patients with esophageal cancer. Ann Thorac Cardiovasc Surg. 2014;20(6):951–60.PubMedGoogle Scholar
  21. 21.
    Prenzel KL, Holscher AH, Drebber U, Agavonova M, Gutschow CA, Bollschweiler E. Prognostic impact of nodal micrometastasis in early esophageal cancer. Eur J Surg Oncol. 2012;38(4):314–8.PubMedGoogle Scholar
  22. 22.
    Koenig AM, Prenzel KL, Bogoevski D, Yekebas EF, Bubenheim M, Faithova L, et al. Strong impact of micrometastatic tumor cell load in patients with esophageal carcinoma. Ann Surg Oncol. 2009;16(2):454–62.PubMedGoogle Scholar
  23. 23.
    Shiozaki H, Fujiwara Y, Hirai T. Clinical significance of immunohistochemically detected lymph node micrometastasis in patients with histologically node-negative esophagealcarcinoma: a multi-institutional study. Esophagus. 2007;4:35–9.Google Scholar
  24. 24.
    Tanabe T, Nishimaki T, Watanabe H, Ajioka Y, Akazawa K, Komukai S, et al. Immunohistochemically detected micrometastasis in lymph nodes from superficial esophageal squamous cell carcinoma. J Surg Oncol. 2003;82(3):153–9.PubMedGoogle Scholar
  25. 25.
    Komukai S, Nishimaki T, Suzuki T, Kanda T, Kuwabara S, Hatakeyama K. Significance of immunohistochemical nodal micrometastasis as a prognostic indicator in potentially curable oesophageal carcinoma. Br J Surg. 2002;89(2):213–9.PubMedGoogle Scholar
  26. 26.
    Doki Y, Ishikawa O, Mano M, Hiratsuka M, Sasaki Y, Kameyama M, et al. Cytokeratin deposits in lymph nodes show distinct clinical significance from lymph node micrometastasis in human esophageal cancers. J Surg Res. 2002;107(1):75–81.PubMedGoogle Scholar
  27. 27.
    Sato F, Shimada Y, Li Z, Watanabe G, Maeda M, Imamura M. Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma. Br J Surg. 2001;88(3):426–32.PubMedGoogle Scholar
  28. 28.
    Glickman JN, Torres C, Wang HH, Turner JR, Shahsafaei A, Richards WG, et al. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma. Cancer. 1999;85(4):769–78.PubMedGoogle Scholar
  29. 29.
    Matsumoto M, Natsugoe S, Ishigami S, Uenosono Y, Takao S, Aikou T. Rapid immunohistochemical detection of lymph node micrometastasis during operation for upper gastrointestinal carcinoma. Br J Surg. 2003;90(5):563–6.PubMedGoogle Scholar
  30. 30.
    Noura S, Yamamoto H, Miyake Y, Kim B, Takayama O, Seshimo I, et al. Immunohistochemical assessment of localization and frequency of micrometastases in lymph nodes of colorectal cancer. Clin Cancer Res. 2002;8(3):759–67.PubMedGoogle Scholar
  31. 31.
    Li SH, Wang Z, Liu XY, Liu FY, Sun ZY, Xue H. Lymph node micrometastasis: a predictor of early tumor relapse after complete resection of histologically node-negative esophageal cancer. Surg Today. 2007;37(12):1047–52.PubMedGoogle Scholar
  32. 32.
    Godfrey TE, Raja S, Finkelstein SD, Gooding WE, Kelly LA, Luketich JD. Prognostic value of quantitative reverse transcription-polymerase chain reaction in lymph node-negative esophageal cancer patients. Clin Cancer Res. 2001;7(12):4041–8.PubMedGoogle Scholar
  33. 33.
    Xi L, Luketich JD, Raja S, Gooding WE, Litle VR, Coello MC, et al. Molecular staging of lymph nodes from patients with esophageal adenocarcinoma. Clin Cancer Res. 2005;11(3):1099–109.PubMedGoogle Scholar
  34. 34.
    Sun ZG, Wang Z, Liu XY, Liu FY. Mucin 1 and vascular endothelial growth factor C expression correlates with lymph node metastatic recurrence in patients with N0 esophageal cancer after Ivor-Lewis esophagectomy. World J Surg. 2011;35(1):70–7.PubMedGoogle Scholar
  35. 35.
    Gerhard M, Juhl H, Kalthoff H, Schreiber HW, Wagener C, Neumaier M. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol. 1994;12(4):725–9.PubMedGoogle Scholar
  36. 36.
    Song ZB, Gao SS, Yi XN, Li YJ, Wang QM, Zhuang ZH, et al. Expression of MUC1 in esophageal squamous-cell carcinoma and its relationship with prognosis of patients from Linzhou city, a high incidence area of northern China. World J Gastroenterol. 2003;9(3):404–7.PubMedPubMedCentralGoogle Scholar
  37. 37.
    Wang Z, Yin H. Diagnosis of occult metastasis to mediastinal lymph nodes in patients with NSCLC: detection of MUC1 mRNA by reverse transcriptase-polymerase chain reaction (RT-PCR). Zhongguo Fei Ai Za Zhi. 2002;5(3):191–3.PubMedGoogle Scholar
  38. 38.
    Kuo CT, Hoon DS, Takeuchi H, Turner R, Wang HJ, Morton DL, et al. Prediction of disease outcome in melanoma patients by molecular analysis of paraffin-embedded sentinel lymph nodes. J Clin Oncol. 2003;21(19):3566–72.PubMedGoogle Scholar
  39. 39.
    Yanagita S, Natsugoe S, Uenosono Y, Arigami T, Funasako Y, Hirata M, et al. The utility of rapid diagnosis of lymph node metastasis in gastric cancer using a multiplex real-time reverse transcription polymerase chain reaction assay. Oncology. 2009;77(3–4):205–11.PubMedGoogle Scholar
  40. 40.
    Nakamura T, Ide H, Eguchi R, Hayashi K, Ota M, Takasaki K. Clinical implications of lymph node micrometastasis in patients with histologically node-negative (pN0) esophageal carcinoma. J Surg Oncol. 2002;79(4):224–9.PubMedGoogle Scholar
  41. 41.
    Zingg U, Montani M, Busch M, Metzger U, Went P, Oertli D. Prognostic influence of immunohistochemically detected lymph node micrometastasis and histological subtype in pN0 oesophageal cancer. Eur J Surg Oncol. 2009;35(6):593–9.PubMedGoogle Scholar
  42. 42.
    Cai J, Ikeguchi M, Maeta M, Kaibara N. Micrometastasis in lymph nodes and microinvasion of the muscularis propria in primary lesions of submucosal gastric cancer. Surgery. 2000;127(1):32–9.PubMedGoogle Scholar
  43. 43.
    Maehara Y, Oshiro T, Endo K, Baba H, Oda S, Ichiyoshi Y, et al. Clinical significance of occult micrometastasis lymph nodes from patients with early gastric cancer who died of recurrence. Surgery. 1996;119(4):397–402.PubMedGoogle Scholar
  44. 44.
    Harrison LE, Choe JK, Goldstein M, Meridian A, Kim SH, Clarke K. Prognostic significance of immunohistochemical micrometastases in node negative gastric cancer patients. J Surg Oncol. 2000;73(3):153–7.PubMedGoogle Scholar
  45. 45.
    Nakajo A, Natsugoe S, Ishigami S, Matsumoto M, Nakashima S, Hokita S, et al. Detection and prediction of micrometastasis in the lymph nodes of patients with pN0 gastric cancer. Ann Surg Oncol. 2001;8(2):158–62.PubMedGoogle Scholar
  46. 46.
    Schoenfeld A, Luqmani Y, Smith D, O’Reilly S, Shousha S, Sinnett HD, et al. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res. 1994;54(11):2986–90.PubMedGoogle Scholar
  47. 47.
    Gu CD, Osaki T, Oyama T, Inoue M, Kodate M, Dobashi K, et al. Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer: impact on recurrence and survival. Ann Surg. 2002;235(1):133–9.PubMedPubMedCentralGoogle Scholar
  48. 48.
    Niedergethmann M, Rexin M, Hildenbrand R, Knob S, Sturm JW, Richter A, et al. Prognostic implications of routine, immunohistochemical, and molecular staging in resectable pancreatic adenocarcinoma. Am J Surg Pathol. 2002;26(12):1578–87.PubMedGoogle Scholar
  49. 49.
    Sasaki E, Nagino M, Ebata T, Oda K, Arai T, Nishio H, et al. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with gallbladder carcinoma. Ann Surg. 2006;244(1):99–105.PubMedPubMedCentralGoogle Scholar
  50. 50.
    Hermanek P, Hutter RV, Sobin LH, Wittekind C. International Union Against Cancer. Classification of isolated tumor cells and micrometastasis. Cancer. 1999;86(12):2668–73.PubMedGoogle Scholar
  51. 51.
    Yanagita S, Natsugoe S, Uenosono Y, Kozono T, Ehi K, Arigami T, et al. Sentinel node micrometastases have high proliferative potential in gastric cancer. J Surg Res. 2008;145(2):238–43.PubMedGoogle Scholar
  52. 52.
    Qubain SW, Natsugoe S, Matsumoto M, Nakashima S, Baba M, Takao S, et al. Micrometastases in the cervical lymph nodes in esophageal squamous cell carcinoma. Dis Esophagus. 2001;14(2):143–8.PubMedGoogle Scholar
  53. 53.
    Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127(4):392–9.PubMedGoogle Scholar
  54. 54.
    Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220(3):391–8. discussion 8-401PubMedPubMedCentralGoogle Scholar
  55. 55.
    Uenosono Y, Natsugoe S, Ehi K, Arigami T, Hokita S, Aikou T. Detection of sentinel nodes and micrometastases using radioisotope navigation and immunohistochemistry in patients with gastric cancer. Br J Surg. 2005;92(7):886–9.PubMedGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Itaru Omoto
    • 1
    Email author
  • Yasuto Uchikado
    • 1
  • Ken Sasaki
    • 1
  • Takaaki Arigami
    • 1
  • Shoji Natsugoe
    • 1
  1. 1.Department of Digestive Surgery, Breast and Thyroid SurgeryKagoshima University Graduate School of Medical and Dental SciencesKagoshimaJapan

Personalised recommendations